" /> Autologous CD20-4SCAR-expressing T-cells 4SCAR20 - CISMeF





Preferred Label : Autologous CD20-4SCAR-expressing T-cells 4SCAR20;

NCIt synonyms : CD20-specific 4th Generation Chimeric Antigen Receptor-modified T Cells; Anti-CD20-CD28-CD137-CD27-CD3z-iCasp9 CAR T-cells 4SCAR20; CD20-4SCAR-expressing T Lymphocytes; 4S-CD20-CAR-T Cell; Anti-CD20 CAR-T Cells 4SCAR20; 4SCAR20 T-cells; CD20-scFv/CD28/CD137/CD27/CD3z-iCasp9 T-cells;

NCIt definition : A preparation of genetically modified autologous T-cells transduced with a replication incompetent, self-inactivating lentiviral vector expressing a fourth generation chimeric antigen receptor (4SCAR) consisting of an anti-CD20 single chain variable fragment (scFv) that is coupled to the costimulatory signaling domains CD28, CD137, CD27 and the zeta chain of the T-cell receptor (TCR), and is fused with the suicide gene inducible caspase 9 (iCasp9), with potential immunostimulating and antineoplastic activities. Upon intravenous administration, autologous CD20-4SCAR-expressing T-cells 4SCAR20 are directed to and induce selective toxicity in CD20-expressing tumor cells. iCasp9 consists of a human FK506 drug-binding domain with an F36V mutation (FKBP12-F36V) linked to human caspase 9. If the administered T-cells lead to unacceptable side effects, the chemical homodimerizer AP1903 can be administered. AP1903 binds to the drug binding FKBP12-F36V domain and induces activation of caspase 9, which results in the apoptosis of the administered T-cells and enhances safety of this agent. CD20 is a non-glycosylated cell surface phosphoprotein that is exclusively expressed on B-cells during most stages of B-cell development and is often overexpressed in B-cell malignancies. CD28, CD137 and CD27, T-cell surface-associated co-stimulatory molecules, are required for full T-cell activation and enhance both proliferation of T-cells and antitumor activity.;

Molecule name : 4SCAR20;

NCI Metathesaurus CUI : CL551140;

Details


You can consult :


Nous contacter.
12/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.